Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock:: impact on biophysical and biochemical surfactant properties

被引:51
作者
Günther, A [1 ]
Schmidt, R [1 ]
Harodt, J [1 ]
Schmehl, T [1 ]
Walmrath, D [1 ]
Ruppert, C [1 ]
Grimminger, F [1 ]
Seeger, W [1 ]
机构
[1] Univ Giessen, Med Klin 2, Zentrum Innere Med, Dept Internal Med 2, D-35392 Giessen, Germany
关键词
acute respiratory distress; syndrome; sepsis; surface tension; surfactant phospholipids;
D O I
10.1183/09031936.02.00243302
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The purpose of the present study was to investigate the impact of bronchoscopic surfactant administration, on the biochemical and biophysical surfactant properties, in patients with severe and early acute respiratory distress syndrome (ARDS) and septic shock. A total number of 27 ARDS patients received 300-500 mg.kg.body.weight(-1) of a natural bovine surfactant extract (Alveofact(R)) via a flexible bronchoscope. Bronchoalveolar lavages were performed 3 h prior to, and 15-18 h and 72 h after surfactant administration. A comparison to healthy volunteers, undergoing an identical lavage procedure, was made (control, n=12). Severe biophysical and biochemical surfactant abnormalities were encountered throughout in the ARDS patients. These included a massive alveolar protein load, a reduced percentage of large surfactant aggregates (LA), a loss of palmitoylated phosphatidylcholine species and a significant reduction of surfactant apoprotein (SP)-A, SP-B and SP-C in the LA fraction. Both minimum (gammamin) and adsorption (gammaads) surface tension values (pulsating bubble surfactometer) were dramatically increased. Surfactant treatment resulted in a marked increase in the lavagable phospholipid (PL) pool, but predominance of the alveolar surfactant-inhibitory protein load was still encountered. Far-reaching or even complete normalization of the PL profile, the LA fraction and its SP-B and SP-C (but not SP-A) content as well as the fatty acid composition of the phosphatidylcholine class was noted. Surface tension lowering properties (gammamin and gammaads) significantly improved, but were still not fully normalized. Bronchoscopic administration of large quantities of natural bovine surfactant in severe acute respiratory distress syndrome causes far-reaching restoration of biochemical surfactant properties and significant improvement, however not full normalization, of biophysical surfactant function.
引用
收藏
页码:797 / 804
页数:8
相关论文
共 35 条
[1]   PRECURSOR-PRODUCT RELATIONSHIP BETWEEN RABBIT TYPE-II CELL LAMELLAR BODIES AND ALVEOLAR SURFACE-ACTIVE MATERIAL - SURFACTANT TURNOVER TIME [J].
BARITUSSIO, AG ;
MAGOON, MW ;
GOERKE, J ;
CLEMENTS, JA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 666 (03) :382-393
[2]   GAS-EXCHANGE AND LUNG MORPHOLOGY AFTER SURFACTANT REPLACEMENT IN EXPERIMENTAL ADULT RESPIRATORY-DISTRESS SYNDROME INDUCED BY REPEATED LUNG LAVAGE [J].
BERGGREN, P ;
LACHMANN, B ;
CURSTEDT, T ;
GROSSMANN, G ;
ROBERTSON, B .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1986, 30 (04) :321-328
[3]   THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION [J].
BERNARD, GR ;
ARTIGAS, A ;
BRIGHAM, KL ;
CARLET, J ;
FALKE, K ;
HUDSON, L ;
LAMY, M ;
LEGALL, JR ;
MORRIS, A ;
SPRAGG, R ;
COCHIN, B ;
LANKEN, PN ;
LEEPER, KV ;
MARINI, J ;
MURRAY, JF ;
OPPENHEIMER, L ;
PESENTI, A ;
REID, L ;
RINALDO, J ;
VILLAR, J ;
VANASBECK, BS ;
DHAINAUT, JF ;
MANCEBO, J ;
MATTHAY, M ;
MEYRICK, B ;
PAYEN, D ;
PERRET, C ;
FOWLER, AA ;
SCHALLER, MD ;
HUDSON, LD ;
HYERS, T ;
KNAUS, W ;
MATTHAY, R ;
PINSKY, M ;
BONE, RC ;
BOSKEN, C ;
JOHANSON, WG ;
LEWANDOWSKI, K ;
REPINE, J ;
RODRIGUEZROISIN, R ;
ROUSSOS, C ;
ANTONELLI, MA ;
BELOUCIF, S ;
BIHARI, D ;
BURCHARDI, H ;
LEMAIRE, F ;
MONTRAVERS, P ;
PETTY, TL ;
ROBOTHAM, J ;
ZAPOL, W .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :818-824
[4]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[5]   PULSATING BUBBLE TECHNIQUE FOR EVALUATING PULMONARY SURFACTANT [J].
ENHORNING, G .
JOURNAL OF APPLIED PHYSIOLOGY, 1977, 43 (02) :198-203
[6]   A MULTICENTER RANDOMIZED CONTROLLED CLINICAL-TRIAL OF BOVINE SURFACTANT FOR PREVENTION OF RESPIRATORY-DISTRESS SYNDROME [J].
GORTNER, L ;
BERNSAU, U ;
HELLWEGE, HH ;
HIERONIMI, G ;
JORCH, G ;
REITER, HL .
LUNG, 1990, 168 :864-869
[7]   Bovine surfactant therapy for patients with acute respiratory distress syndrome [J].
Gregory, TJ ;
Steinberg, KP ;
Spragg, R ;
Gadek, JE ;
Hyers, TM ;
Longmore, WJ ;
Moxley, MA ;
Cai, GZ ;
Hite, RD ;
Smith, RM ;
Hudson, LD ;
Crim, C ;
Newton, P ;
Mitchell, BR ;
Gold, AJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (04) :1309-1315
[8]   SURFACTANT CHEMICAL-COMPOSITION AND BIOPHYSICAL ACTIVITY IN ACUTE RESPIRATORY-DISTRESS SYNDROME [J].
GREGORY, TJ ;
LONGMORE, WJ ;
MOXLEY, MA ;
WHITSETT, JA ;
REED, CR ;
FOWLER, AA ;
HUDSON, LD ;
MAUNDER, RJ ;
CRIM, C ;
HYERS, TM .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (06) :1976-1981
[9]  
Gunther A, 1996, AM J RESP CRIT CARE, V153, P176
[10]  
Günther A, 1999, AM J RESP CRIT CARE, V159, P244